Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was updated; a recruitment notice 'No longer looking for participants' was added. The page version label was updated from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the page metadata. This appears to be an administrative update rather than a substantive change to study content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page. This update does not change the study data or essential information presented.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s footer/version indicator has been updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check94 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.